Sorva A, Tähtelä R, Risteli J, Risteli L, Laitinen K, Juntunen-Backman K, Sorva R
Department of Internal Medicine, Koskela Hospital, Helsinki, Finland.
Clin Chem. 1994 Aug;40(8):1591-3.
We describe a family with an apparently autosomal-dominant trait that caused extremely high circulating concentrations of the carboxyl-terminal propeptide of type I procollagen (PICP). All family members examined had normal values for other biochemical markers of bone formation and degradation and no related clinical abnormalities. Furthermore, their serum concentrations of the amino-terminal propeptide of type I procollagen (PINP) were normal. Although PINP and PICP are released from the same precursor molecule, PINP is cleared from the circulation via the scavenger receptor in liver endothelial cells, whereas PICP is cleared via the mannose receptor of these cells. We thus hypothesize that the clearance of circulating PICP is compromised in the affected subjects of this family, the result of either a defective mannose receptor function or an abnormal molecular structure of their PICP.
我们描述了一个具有明显常染色体显性性状的家族,该性状导致I型前胶原羧基末端前肽(PICP)的循环浓度极高。所有接受检查的家族成员,其骨形成和降解的其他生化标志物值均正常,且无相关临床异常。此外,他们血清中的I型前胶原氨基末端前肽(PINP)浓度也正常。尽管PINP和PICP是从同一前体分子释放出来的,但PINP通过肝内皮细胞中的清道夫受体从循环中清除,而PICP则通过这些细胞的甘露糖受体清除。因此,我们推测在这个家族的患病个体中,循环PICP的清除受到损害,这是甘露糖受体功能缺陷或其PICP分子结构异常的结果。